Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Juli 2026 15:07 ET | Quelle: Robbins LLP

Robbins LLP Urges ERAS Stockholders to Contact the Firm for Information About the Class Action Against Erasca, Inc.

Robbins LLP Urges ERAS Stockholders to Contact the Firm for Information About the Class Action Against Erasca, Inc.
03. Juli 2026 10:00 ET | Quelle: Robbins LLP

EMBC Stockholders Have Rights – If You Lost Money Investing in Embecta Corp. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Embecta Corp. (EMBC) Misled Investors Regarding its Business Prospects
01. Juli 2026 18:21 ET | Quelle: Robbins LLP

GRAL Investors Have Rights – If You Lost Money Investing in Grail, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Grail, Inc. (GRAL) Misled Investors Concerning the Success of its NHS-Galleri Trial
05. Juni 2026 13:57 ET | Quelle: Robbins LLP

Robbins LLP Reminds IMMP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Immutep Limited

Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug Candidate
01. Juni 2026 13:37 ET | Quelle: Robbins LLP

ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit

Robbins LLP is Investigating Allegations that Zeotis Inc. (ZTS) Misled Investors Regarding its Flagship Products as a Durable Growth Engine
06. Mai 2026 15:12 ET | Quelle: Robbins LLP

Medpace Holdings Inc. Class Action Lawsuit – Robbins LLP Reminds MEDP Investors of the Upcoming Lead Plaintiff Deadline; Contact Us Today for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
14. April 2026 17:27 ET | Quelle: Robbins LLP

Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDP

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
26. März 2026 17:28 ET | Quelle: Robbins LLP

ATRA Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Atara Biotherapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Atara Biotherapeutics, Inc. (ATRA) Misled Investors Regarding its Drug Candidate
05. März 2026 14:21 ET | Quelle: Robbins LLP

POM Class Action: POMDoctor Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme
04. März 2026 13:40 ET | Quelle: Robbins LLP

Robbins LLP Urges MREO Stockholders to Contact the Firm for Information About the Class Action Against Mereo BioPharma Group plc

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab

Nächste Seite